Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-11
2007-12-11
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S235500, C544S129000, C546S187000
Reexamination Certificate
active
10480625
ABSTRACT:
The invention provides a compound of formula (I), wherein: T is C(O) or S(O)2; W is C(O) or S(O)2; X is CH2, O or NH; Y is CR5or N; R1is optionally substituted aryl or optionally substituted heterocyclyl; R2is hydrogen or C1-6alkyl; R3is hydrogen or optionally substituted C1-6alkyl; and R4is alkyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted heterocyclyl; that are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis
REFERENCES:
patent: 4695575 (1987-09-01), Janssens et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5889006 (1999-03-01), Lowe et al.
patent: 5952349 (1999-09-01), Asberom et al.
patent: 5977138 (1999-11-01), Wang et al.
patent: 6066636 (2000-05-01), Kozlowski et al.
patent: 6387930 (2002-05-01), Baroudy et al.
patent: 6440440 (2002-08-01), Meerpoel et al.
patent: 6759411 (2004-07-01), Ko et al.
patent: 6903115 (2005-06-01), Rigby et al.
patent: 0 099 139 (1984-01-01), None
patent: 0 121 972 (1984-10-01), None
patent: 0 145 037 (1985-06-01), None
patent: 0 151 824 (1985-08-01), None
patent: 0 151 826 (1985-08-01), None
patent: 1 076 055 (2001-02-01), None
patent: 1250719 (1971-10-01), None
patent: WO93/10091 (1993-05-01), None
patent: WO95/08535 (1995-03-01), None
patent: WO96/26196 (1996-08-01), None
patent: WO96/34857 (1996-11-01), None
patent: WO96/41631 (1996-12-01), None
patent: WO97/24324 (1997-07-01), None
patent: WO98/01425 (1998-01-01), None
patent: WO98/05291 (1998-02-01), None
patent: WO 98/05292 (1998-02-01), None
patent: WO98/05292 (1998-02-01), None
patent: WO 98/06697 (1998-02-01), None
patent: WO98/06697 (1998-02-01), None
patent: WO98/11128 (1998-03-01), None
patent: WO99/04794 (1999-02-01), None
patent: WO99/37304 (1999-07-01), None
patent: WO99/38514 (1999-08-01), None
patent: WO99/51578 (1999-10-01), None
patent: WO 00/00488 (2000-01-01), None
patent: WO 00/12478 (2000-03-01), None
patent: WO 00/32590 (2000-06-01), None
patent: WO 00/35877 (2000-06-01), None
patent: WO 00/66559 (2000-11-01), None
patent: WO 01/02381 (2001-01-01), None
patent: WO 01/07436 (2001-02-01), None
patent: WO 01/29066 (2001-04-01), None
patent: WO 01/77101 (2001-10-01), None
patent: WO 01/92227 (2001-12-01), None
patent: WO 02/18335 (2002-03-01), None
patent: WO 02/20484 (2002-03-01), None
patent: WO 02/079190 (2002-10-01), None
patent: WO 02/079194 (2002-10-01), None
patent: WO 02/081449 (2002-10-01), None
patent: WO 03/018576 (2003-03-01), None
patent: WO 03/020716 (2003-03-01), None
patent: WO 03/024962 (2003-03-01), None
patent: WO 03/078395 (2003-09-01), None
patent: WO 03/078421 (2003-09-01), None
patent: WO 2004/029041 (2004-04-01), None
patent: WO 2004/085423 (2004-10-01), None
patent: WO 2004/087659 (2004-10-01), None
patent: WO 2004/099144 (2004-11-01), None
patent: WO 2004/113323 (2004-12-01), None
Cohen et al., Am. J. Clin. Pathol., 1996, 105, 589.
Patani et al., Chem. Rev., 1996, 96, pp. 3147-3176.
U.S. Appl. No. 10/341,027, filed Jan. 8, 2004, Lawrence et al.
Allain et al., (2005) STN International, HCAPLUS Database, Columbus, OH, Accession No. 1992:187881, Reg. No. 46817-91-8, citing “Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline”,Psychopharmacology106 (Suppl.).
Hermans et al., “4-Substituted Piperidines. II. Reaction of 1-Benzyl-4-cyano-4-t-aminopiperidines with Organometallic Compounds”,J. Med. Chem.8(6):851-855 (1965) at p. 852 (“compound 12”in Table I).
STN International, File Caplus, Caplus accession No. 1988:630911, Document No. 109:230911, Lehmann, Jochen et al: “Lactones. XVIII. Synthesis of lactone-bridged 1,1-diarylpropanamines”; &Arch. Pharm.(Weinheim, Ger.) (1988), 321(7), 443-445.
Harada et al., Novel N-[1-Substituted 4-Piperidinylmethyl)-4-piperidinyl] benzamides as potent Colonic Prokinetic Agents, Bioorganic & Medicinal Chemistry Letters 12:967-970, 2002.
Evans Richard
Perry Matthew
Springthorpe Brian
AstraZeneca AB
Chang Celia
LandOfFree
Piperidine derivatives useful as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives useful as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives useful as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3829170